DCTD Programs
Last Updated: 03/27/2023
2023 News

Posted March 27, 2023
Source: DCTD Meetings
Preventing Resistance to Cancer Targeted Therapies
Posted March 17, 2023
Source: NCI Cancer Currents Blog
Tucatinib Approved for HER2-Positive Colorectal Cancer
Posted February 10, 2023
Source: NCI Cancer Currents Blog
Blinatumomab Extends Life for People with ALL in Remission
Posted January 25, 2023
Source: NCI Cancer Currents Blog
Kisqali Plus Hormone Therapy for Metastatic Breast Cancer
Posted January 11, 2023
Source: NCI Cancer Currents Blog